UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Symptom burden and surgical outcome in non-skull base meningiomas

Frontiers in oncology, 2022-09, Vol.12, p.967420-967420

2022

Volltextzugriff (PDF)

Surgical resection of brain metastases-impact on neurological outcome

International journal of molecular sciences, 2013-04, Vol.14 (5), p.8708-8718

2013

Volltextzugriff (PDF)

Breakouts-A Radiological Sign of Poor Prognosis in Patients With Brain Metastases

Frontiers in oncology, 2022-04, Vol.12, p.849880-849880

2022

Volltextzugriff (PDF)

Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients

Neuro-oncology (Charlottesville, Va.), 2015-06, Vol.17 (6), p.784-800

2015

Volltextzugriff (PDF)

QOL-02. FACTORS INFLUENCING COMPLIANCE IN TTF TREATMENT – THE COMPTUNE STUDY

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii240-vii241

2022

Volltextzugriff (PDF)

Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets

Genes chromosomes & cancer, 2015-07, Vol.54 (7), p.433-443

2015

Volltextzugriff (PDF)

Early postoperative tumor progression predicts clinical outcome in glioblastoma—implication for clinical trials

Journal of neuro-oncology, 2017-04, Vol.132 (2), p.249-254

2017

Volltextzugriff (PDF)

Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)

Neuro-oncology (Charlottesville, Va.), 2018-02, Vol.20 (3), p.400-410

2018

Volltextzugriff (PDF)

Discrepancies between the MRI- and the electrophysiologically defined subthalamic nucleus

Acta neurochirurgica, 2011-12, Vol.153 (12), p.2307-2318

2011

Volltextzugriff (PDF)

ACTR-20. FINDING A PREDICTIVE MARKER FOR COMPLIANCE TO TTFIELDS THERAPY – THE COMPTUNE STUDY

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi4-vi5

2017

Volltextzugriff (PDF)

RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study

BMC cancer, 2009-09, Vol.9 (1), p.308-308, Article 308

2009

Volltextzugriff (PDF)

The influence of intraoperative microelectrode recordings and clinical testing on the location of final stimulation sites in deep brain stimulation for Parkinson’s disease

Acta neurochirurgica, 2013-02, Vol.155 (2), p.357-366

2013

Volltextzugriff (PDF)

External validation and recalibration of an incidental meningioma prognostic model – IMPACT: protocol for an international multicentre retrospective cohort study

BMJ open, 2022-01, Vol.12 (1), p.e052705-e052705

2022

Volltextzugriff (PDF)

Growth pattern analysis of sphenoid wing meningiomas

Acta neurochirurgica, 2010, Vol.152 (1), p.99-103

2010

Volltextzugriff (PDF)

Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM 1 and CMTM 3 as priority targets

Genes chromosomes & cancer, 2015-07, Vol.54 (7), p.433-443

2015

Volltextzugriff (PDF)

Calcitonin-gene related peptide and cerebral vasospasm

Journal of clinical neuroscience, 2013-04, Vol.20 (4), p.584-586

2013

Volltextzugriff (PDF)

Neuropeptide Y - an early biomarker for cerebral vasospasm after aneurysmal subarachnoid hemorrhage

Neurological research (New York), 2013-12, Vol.35 (10), p.1038-1043

2013

Volltextzugriff (PDF)

Deep brain stimulation in Parkinson’s disease: motor effects relative to the MRI-defined STN

Neurosurgical review, 2014-07, Vol.37 (3), p.461-471

2014

Volltextzugriff (PDF)

Differences in Neuropeptide Y Secretion Between Intracerebral Hemorrhage and Aneurysmal Subarachnoid Hemorrhage

Journal of neurosurgical anesthesiology, 2017-07, Vol.29 (3), p.312-316

2017

Volltextzugriff (PDF)

The possible role of neuropeptide Y after spontaneous subarachnoid hemorrhage

Acta neurochirurgica, 2011-08, Vol.153 (8), p.1663-1668

2011

Volltextzugriff (PDF)

Morphology of Middle Cerebral Artery Aneurysms: Impact on Surgical Strategy and on Postoperative Outcome

ISRN stroke, 2013-03, Vol.2013, p.1-7

2013

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Acta Neurochirurgica
(4)
Neuro-Oncology
(4)
Cancers
(2)
Frontiers In Oncology
(2)
Genes Chromosomes & Cancer
(2)
Bmc Cancer
(1)
Bmj Open
(1)
British Journal Of Cancer
(1)
International Journal Of Molecular Sciences
(1)
Isrn Stroke
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Symptom burden and surgical outcome in non-skull base meningiomas

Surgical resection of brain metastases-impact on neurological outcome

Breakouts-A Radiological Sign of Poor Prognosis in Patients With Brain Metastases

Validation Study for Non-Invasive Prediction of IDH Mutation Status in Patients with Glioma Using In Vivo 1H-Magnetic Resonance Spectroscopy and Machine Learning

Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients

Validation Study for Non-Invasive Prediction of IDH Mutation Status in Patients with Glioma Using In Vivo 1 H-Magnetic Resonance Spectroscopy and Machine Learning

QOL-02. FACTORS INFLUENCING COMPLIANCE IN TTF TREATMENT – THE COMPTUNE STUDY

Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets

Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre

Early postoperative tumor progression predicts clinical outcome in glioblastoma—implication for clinical trials

Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)

Discrepancies between the MRI- and the electrophysiologically defined subthalamic nucleus

ACTR-20. FINDING A PREDICTIVE MARKER FOR COMPLIANCE TO TTFIELDS THERAPY – THE COMPTUNE STUDY

RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study

The influence of intraoperative microelectrode recordings and clinical testing on the location of final stimulation sites in deep brain stimulation for Parkinson’s disease

External validation and recalibration of an incidental meningioma prognostic model – IMPACT: protocol for an international multicentre retrospective cohort study

Growth pattern analysis of sphenoid wing meningiomas

Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM 1 and CMTM 3 as priority targets

Cancer-associated cells release citrate to support tumour metastatic progression

Calcitonin-gene related peptide and cerebral vasospasm

Neuropeptide Y - an early biomarker for cerebral vasospasm after aneurysmal subarachnoid hemorrhage

Deep brain stimulation in Parkinson’s disease: motor effects relative to the MRI-defined STN

Differences in Neuropeptide Y Secretion Between Intracerebral Hemorrhage and Aneurysmal Subarachnoid Hemorrhage

The possible role of neuropeptide Y after spontaneous subarachnoid hemorrhage

Morphology of Middle Cerebral Artery Aneurysms: Impact on Surgical Strategy and on Postoperative Outcome

Suchergebnisse filtern